Gonorrhea
MONDO:0004277A common sexually transmitted bacterial infection caused by Neisseria gonorrhoeae. It is transmitted through vaginal, oral, or anal intercourse. Infected individuals may be asymptomatic. Symptoms in males include burning sensation during urination, discharge from the penis, and painful swelling of the testes. Symptoms in females include painful urination, vaginal discharge, and vaginal bleeding between periods. If untreated, the infection may lead to pelvic inflammatory disease.
Also known as: GC, Neisseria gonorrhoeae infection, Crosti-gianotti syndrome, Gianotti Crosti syndrome, PAC, PAS, acrodermatitis, infantile lichenoid, acrodermatitis, papular infantile
45 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
-
Could a simple cup cut STIs and BV? new trial hopes so
Disease control OngoingThis study tests whether giving menstrual cups to economically vulnerable women in Kenya can lower rates of bacterial vaginosis (BV) and sexually transmitted infections (STIs). The cup is a reusable silicone device that collects menstrual blood and can be worn during sex. Researc…
Phase: PHASE2 • Sponsor: Rush University Medical Center • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Can a common antibiotic prevent STIs? new study tests two dosing strategies
Prevention OngoingThis study tests whether taking doxycycline before potential exposure to STIs works better than taking it after exposure. 300 men who have sex with men will be randomly assigned to one of two groups and followed for 2 years. The goal is to see which approach better prevents chlam…
Phase: PHASE4 • Sponsor: Chinese University of Hong Kong • Aim: Prevention
Last updated Jun 27, 2026 13:02 UTC
-
Meningitis b vaccine tested as gonorrhea shield in men
Prevention OngoingThis Phase 3 trial tests whether a meningitis B vaccine (Bexsero) can prevent gonorrhea infections in men who have sex with men. 150 participants in Hong Kong will receive either the vaccine or a placebo. Researchers will compare infection rates and monitor safety.
Phase: PHASE3 • Sponsor: Chinese University of Hong Kong • Aim: Prevention
Last updated Jun 27, 2026 11:03 UTC